<?xml version='1.0' encoding='utf-8'?>
<document id="10602164"><sentence text="Ciprofloxacin-warfarin coagulopathy: a case series."><entity charOffset="0-13" id="DDI-PubMed.10602164.s1.e0" text="Ciprofloxacin" /></sentence><sentence text="Ciprofloxacin, when given to patients previously anticoagulated with warfarin, can occasionally cause an exaggerated hypoprothombinemic response and bleeding diatheses"><entity charOffset="0-13" id="DDI-PubMed.10602164.s2.e0" text="Ciprofloxacin" /></sentence><sentence text=" Two such cases encountered at our institution are presented and data is combined with 64 cases reported to the Food and Drug Administration's (FDA) Spontaneous Reporting System (SRS) database, which included all cases reported from 1987 through 1997" /><sentence text=" Of 66 total cases the median age was 72 (range 36-94)" /><sentence text=" The mean time to detection of the coagulopathy following the ciprofloxacin challenge was 5"><entity charOffset="62-75" id="DDI-PubMed.10602164.s5.e0" text="ciprofloxacin" /></sentence><sentence text="5 days (n = 50)" /><sentence text=" Hospitalization was reported in 15 cases, bleeding in 25 cases, and death in one case" /><sentence text=" The median prothrombin time (PT) and International Normalized Ratio (INR) was 38" /><sentence text="0 (n = 13) and 10" /><sentence text="0 (n = 23), respectively" /><sentence text=" The mean number of medications taken was 6" /><sentence text="5 (n = 45)" /><sentence text=" The mean time to correction was significantly shorter between the treated (2" /><sentence text="5 days) and the untreated (4" /><sentence text="0 days) groups (P &lt; 0" /><sentence text=" 008)" /><sentence text=" The ciprofloxacin-warfarin coagulopathy occurred most commonly in patients in their seventh decade and in those who require polypharmacy"><entity charOffset="5-18" id="DDI-PubMed.10602164.s17.e0" text="ciprofloxacin" /></sentence><sentence text=" Active treatment of the coagulopathy results in more rapid resolution than observation alone" /><sentence text=" Clinicians should be aware of the potential bleeding complications that can occur with the ciprofloxacin-warfarin drug-drug interaction"><entity charOffset="92-105" id="DDI-PubMed.10602164.s19.e0" text="ciprofloxacin" /></sentence><sentence text="" /></document>